Tag: EGFR-mutant NSCLC

Illustration showing the lungs with a tumor, a vial representing medication, and surgical tools, indicating lung cancer treatment involving toripalimab.

Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in final phase 3 results

by2 Minute Medicine

October 26, 2026

Company-reported final results showed sacituzumab tirumotecan improved overall survival versus platinum-based chemotherapy in EGFR-mutant advanced NSCLC.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.